Previous studies on lipid metabolism showed that patients with higher lung cancer having high levels of high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein (LDL), and low-density lipoprotein receptor (LDLR) have better survival rates (11, 12). This evidence concerns the gene LDLR and lung cancer.